Correlation Between Organogenesis Holdings and Shuttle Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Organogenesis Holdings and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Organogenesis Holdings and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Organogenesis Holdings and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Organogenesis Holdings and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Organogenesis Holdings with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Organogenesis Holdings and Shuttle Pharmaceuticals.

Diversification Opportunities for Organogenesis Holdings and Shuttle Pharmaceuticals

-0.66

Correlation Coefficient

Organogenesis Holdings  Shuttle Pharmaceuticals

Excellent diversification

The 3 months correlation between Organogenesis and Shuttle is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Organogenesis Holdings and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Organogenesis Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Organogenesis Holdings are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Organogenesis Holdings i.e., Organogenesis Holdings and Shuttle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Organogenesis Holdings and Shuttle Pharmaceuticals

Given the investment horizon of 90 days Organogenesis Holdings is expected to generate 0.63 times more return on investment than Shuttle Pharmaceuticals. However, Organogenesis Holdings is 1.59 times less risky than Shuttle Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest  288.00  in Organogenesis Holdings on August 30, 2024 and sell it today you would earn a total of  102.00  from holding Organogenesis Holdings or generate 35.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Organogenesis Holdings  vs.  Shuttle Pharmaceuticals

Organogenesis Holdings

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Organogenesis Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Organogenesis Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Shuttle Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Organogenesis Holdings and Shuttle Pharmaceuticals

The main advantage of trading using opposite Organogenesis Holdings and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Organogenesis Holdings position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.

The idea behind Organogenesis Holdings and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.